an overview of recent metastatic her2 breast cancer trials
Published 4 years ago • 113 plays • Length 4:44Download video MP4
Download video MP3
Similar videos
-
7:13
overview of the management of her2-low breast cancer patients
-
5:57
phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer patients
-
2:23
an overview of the neomonarch trial in hr /her2- breast cancer
-
4:01
management of her2 positive metastatic breast cancer treatment algorithm
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
6:00
an overview of breast cancer in malaysia
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
1:30
tucatinib in her2 breast cancer with leptomeningeal metastases
-
2:43
study of ds-8201a in her2-low, unresectable and/or metastatic breast cancer
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
2:15
treatment strategies for her2 metastatic breast cancer
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
6:21
emerging agents for her2 mbc: her2climb and sophia trials
-
4:34
the best sequence of anti-her2 therapy in metastatic breast cancer
-
2:43
margetuximab for the treatment of her2-positive breast cancer
-
1:09
latest updates in her2-positive metastatic breast cancer: the nala and sophia trials
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases